boehringer ingelheim glp-1 🚨 Survodutide, a weekly subcutaneous dual GLP-1/glucagon agonist, posts new top-line Phase 3 results today 📊 SYNCHRONIZE-1: Adults with overweight/obesity randomized to survodutide vs. placebo for 76 weeks ⚖️ 16.6% weight loss ( New data cast doubt on

If you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting, or you may feel the pain from your abdomen to your back

The research specifically examines how the maturation of SREBP2 as a transcription factor affects the expression of GLUT1 and GLUT6 in glioma cells

Mar 2002;45(3):420-426

In the normal LH group, the increase was from 4.2 to 5.9 IU/mL, still nothing to sneeze at (although not significant statistically.) Increases in estrogen were also seen (similar to the first study) from 29.9 to 40.8 in the low LH group and 37.4 to 52 in the normal LH group

Researchers have found that inflammatory cytokines induce the expression of COX-2 (a chief driver of pain and inflammation among many chronic diseases) in the osteoblasts (cells responsible for the synthesis and mineralization of bones) of inflamed joints

Nutritional support with protein, vitamin C, zinc, and collagen peptides provides raw materials for tissue repair